Regulatory and strategic challenges of patent evergreening in the MedTech industry: An analysis of competition law implications
- Title
- Regulatory and strategic challenges of patent evergreening in the MedTech industry: An analysis of competition law implications
- Creator
- Beerannavar, Chaitra Rangappa; Koshi, Sandra Mariya
- Description
- Patent evergreening is a strategy used by pharmaceutical companies to extend their market exclusivity through minor modifications of existing drugs, often without significant therapeutic advancements. This practice raises concerns about access to affordable medicines, particularly in developing countries like India, where high drug prices impact public health. A comparative analysis with the European Union (EU) reveals that while India relies on patent law restrictions, the EU employs competition law under Article 102 of the Treaty on the Functioning of the European Union (TFEU) to regulate evergreening. Cases such as AstraZeneca v. European Commission demonstrate the EU's effects-based approach to curbing anti-competitive patent strategies. This study highlights the gaps in India's regulatory framework, emphasizing the need for greater coordination between the Indian Patent Office (IPO) and the Competition Commission of India (CCI), and adopting an effects-based approach are crucial to preventing evergreening while ensuring both innovation and consumer welfare. 2025, IGI Global Scientific Publishing. All rights reserved.
- Source
- Strategic Management, Regulatory Challenges, and Global Governance of MedTech;pp.149-183
- Date
- 01-01-2025
- Publisher
- IGI Global
- Coverage
- Beerannavar C.R., Christ University, India; Koshi S.M., Christ University, India
- Rights
- Restricted Access; Hardcopy may be available in the library
- Relation
- ISBN: 979-833731207-1; 979-833731205-7;
- Format
- online
- Language
- English
- Type
- Book chapter
Collection
Citation
Beerannavar, Chaitra Rangappa; Koshi, Sandra Mariya, “Regulatory and strategic challenges of patent evergreening in the MedTech industry: An analysis of competition law implications,” CHRIST (Deemed To Be University) Institutional Repository, accessed June 19, 2026, https://archives.christuniversity.in/items/show/24609.
